Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-02-07
2006-02-07
Seaman, D. Margaret (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S313000, C514S314000, C514S343000, C514S423000, C514S422000, C546S159000, C546S160000, C546S279100, C546S153000, C548S537000
Reexamination Certificate
active
06995174
ABSTRACT:
Hepatitis C virus inhibitors are disclosed having the general formula:wherein R1, R2, R3, R′, B, Y and X are described in the description.Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
REFERENCES:
patent: 5633388 (1997-05-01), Diana et al.
patent: 5866684 (1999-02-01), Attwood et al.
patent: 5869253 (1999-02-01), Draper et al.
patent: 6018020 (2000-01-01), Attwood et al.
patent: 6225284 (2001-05-01), Albert et al.
patent: 6265380 (2001-07-01), Tung et al.
patent: 6268207 (2001-07-01), Bailey
patent: 6323180 (2001-11-01), Linas-Brunet et al.
patent: 6410531 (2002-06-01), Linas-Brunet et al.
patent: 6420380 (2002-07-01), Linas-Brunet et al.
patent: 6534523 (2003-03-01), Linas-Brunet et al.
patent: 6642204 (2003-11-01), Llinas-Brunet et al.
patent: 2002/0111313 (2002-08-01), Campbell et al.
patent: 1162196 (2000-12-01), None
patent: WO 95/33764 (1995-12-01), None
patent: WO 97/06804 (1997-02-01), None
patent: WO 97/43310 (1997-11-01), None
patent: WO 98/17679 (1998-04-01), None
patent: WO 98/22496 (1998-05-01), None
patent: WO 98/46597 (1998-10-01), None
patent: WO 98/46630 (1998-10-01), None
patent: WO 99/07733 (1999-02-01), None
patent: WO 99/07734 (1999-02-01), None
patent: WO 99/38888 (1999-08-01), None
patent: WO 99/50230 (1999-10-01), None
patent: WO 99/64442 (1999-12-01), None
patent: WO 00/06529 (2000-02-01), None
patent: WO 00/09543 (2000-02-01), None
patent: WO 00/09558 (2000-02-01), None
patent: WO 00/10573 (2000-03-01), None
patent: WO 00/13708 (2000-03-01), None
patent: WO 00/18231 (2000-04-01), None
patent: WO 00/59929 (2000-10-01), None
patent: WO 01/32153 (2001-05-01), None
patent: WO 01/85172 (2001-11-01), None
patent: WO 02/04425 (2002-01-01), None
patent: WO 02/06246 (2002-01-01), None
patent: WO 02/060926 (2002-08-01), None
patent: WO 03/064416 (2003-08-01), None
patent: WO 03/064455 (2003-08-01), None
patent: WO 03/064456 (2003-08-01), None
patent: WO 03/066103 (2003-08-01), None
Kolykhalov, A.A., J of Virology, vol. 74, No. 4, pp. 2046-2051, Feb. 2000.
Taliani, M., Analytical Biochemistry, vol. 240, pp 80-87, 1998.
Lauer et al. (2001) New England Journal of Medicine, vol. 345 No. 1, pp. 41-52.
Zeuzem et al. (2000) The New England Journal of Medicine, vol. 343 No. 23, pp. 1666-1672.
Poynard et al. (1998) The Lancet, vol. 352, pp. 1426-1432.
Poupart et al. (2001) The Journal of Organic Chemistry, vol. 66 No. 14, pp. 4743-4751.
Steinkuhier et al. (1998) Biochemistry, vol. 37, pp. 8899-8905.
Ingallinella et al. (1998) Biochemistry, vol. 37, pp. 8906-8914.
Chu et al. (1996) Tetrahedron Letters, vol. 37 No. 40, pp. 7229-7232.
Matsumoto et al. (1996) Antiviral Research, vol. 30 No. 1, p. A23, Abstract 19.
Campbell Jeffrey Allen
Chen Yan
Good Andrew Charles
Hewawasam Piyasena
Scola Paul Michael
Seaman D. Margaret
Volles Warren K.
LandOfFree
Hepatitis C virus inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hepatitis C virus inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hepatitis C virus inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3697665